Dr. John M. Timmerman, MD

Expert Publications

• Dendritic cell vaccines for cancer immunotherapy.
• Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.
• The history of the development of vaccines for the treatment of lymphoma.
• BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
• Vaccine therapies for non-Hodgkin's lymphoma.
• Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
• Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
• Immunotherapy for lymphomas.
• Extending the utility of gene profiling data by bridging microarray platforms.
• Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
• Cancer vaccines: pessimism in check.
• Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
• Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
• Vaccine therapies for non-Hodgkin's lymphomas.
• Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.

Media Releases

Get to know Immunologist and Hematologist-Oncologist, Dr. John M. Timmerman, MD, who serves patients in Santa Monica, California.

Dr. Timmerman is a board certified hematologist-oncologist currently practicing at Santa Monica Cancer Care at UCLA Health in Santa Monica, California. Academically, he maintains a position as Associate Professor of Medicine in the UCLA Lymphoma Program, which is part of the Division of Hematology & Oncology in the Department of Medicine at UCLA. Dr. Timmerman is also a member of the Tumor Immunology Program within the UCLA Jonsson Comprehensive Cancer Center and the UCLA Molecular Biology Institute.

Dr. Timmerman earned his medicaid degree in 1991 at the prestigious Boston University School of Medicine in Boston, MAssachusetts. He then served his internship (1991-1992) and internal medicine residency (1992-1994) at the University of California San Francisco School of Medicine in San Francisco, California. In 1998, he completed his fellowship in hematology-oncology at Stanford University School of Medicine in Stanford, California. Prior to medical school, Dr. Timmerman received his undergraduate degrees in biochemistry and physiology from the University of California, Berkeley, and his Master’s degree from Boston University.

Following his training, Dr. Timmerman attained board certification in internal medicine, medical oncology, and hematology through the American Board of Internal Medicine (ABIM). The American Board of Internal Medicine is a 501 nonprofit, self-appointed physician-evaluation organization that certifies physicians practicing internal medicine and its subspecialties. The American Board of Internal Medicine is not a membership society, educational institution, or licensing body.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma.

Oncology is the study of cancer. The field of oncology has three major areas: medical, surgical, and radiation. A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy. A surgical oncologist removes the tumor and nearby tissue during surgery. A radiation oncologist treats cancer using radiation therapy.

Licensed to practice in California, Dr. Timmerman maintains hospital privileges at Ronald Reagan UCLA Medical Center Los Angeles, California, and UCLA Santa Monica Medical Center in Santa Monica, California. Included in Southern California Super Doctors® (2010-2012), he is actively involved in research with a special interest in the treatment of non-Hodgkin and Hodgkin lymphomas, tumor immunology, and immunotherapy of lymphomas. 

Recommended Articles

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• Teen Finds Strength to Give Back After Battling Lymphoma

  Ayden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...

• Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma

  Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....

• Treatments for Multiple Myeloma

  The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...